Human RWDD3 activation kit by CRISPRa
CAT#: GA108654
RWDD3 CRISPRa kit - CRISPR gene activation of human RWD domain containing 3
CNY 12255.00
CNY 1999.00
CNY 2700.00
CNY 2400.00
CNY 3990.00
Specifications
Product Data | |
Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
Symbol | RWDD3 |
Locus ID | 25950 |
Kit Components | GA108654G1, RWDD3 gRNA vector 1 in pCas-Guide-GFP-CRISPRa GA108654G2, RWDD3 gRNA vector 2 in pCas-Guide-GFP-CRISPRa GA108654G3, RWDD3 gRNA vector 3 in pCas-Guide-GFP-CRISPRa 1 CRISPRa-Enhancer vector, SKU GE100056 1 CRISPRa scramble vector, SKU GE100077 |
Reference Data | |
RefSeq | NM_001128142, NM_001199682, NM_001278247, NM_001278248, NM_015485, NR_037643, NR_103483, NR_103484 |
Synonyms | RSUME |
Summary | Enhancer of SUMO conjugation. Via its interaction with UBE2I/UBC9, increases SUMO conjugation to proteins by promoting the binding of E1 and E2 enzymes, thioester linkage between SUMO and UBE2I/UBC9 and transfer of SUMO to specific target proteins which include HIF1A, PIAS, NFKBIA, NR3C1 and TOP1. Isoform 1 and isoform 2 positively regulate the NF-kappa-B signaling pathway by enhancing the sumoylation of NF-kappa-B inhibitor alpha (NFKBIA), promoting its stabilization which consequently leads to an increased inhibition of NF-kappa-B transcriptional activity. Isoform 1 and isoform 2 negatively regulate the hypoxia-inducible factor-1 alpha (HIF1A) signaling pathway by increasing the sumoylation of HIF1A, promoting its stabilization, transcriptional activity and the expression of its target gene VEGFA during hypoxia. Isoform 2 promotes the sumoylation and transcriptional activity of the glucocorticoid receptor NR3C1 and enhances the interaction of SUMO1 and NR3C1 with UBE2I/UBC9. Has no effect on ubiquitination.[UniProtKB/Swiss-Prot Function] |
Documents
Resources
基因表达相关资源 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
KN417602 | RWDD3 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated. |
CNY 8680.00 |